Kera Capital Partners, Inc. Merck & Co., Inc. Transaction History
Kera Capital Partners, Inc.
- $483 Million
- Q2 2025
A detailed history of Kera Capital Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 8,272 shares of MRK stock, worth $669,452. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,272
Previous 3,852
114.75%
Holding current value
$669,452
Previous $346 Million
99.81%
% of portfolio
0.14%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,897Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$20.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.75 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.61 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.83 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $205B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...